BIOMERICA INC (BMRA) Stock Price
BMRAStock
$1.85−38.54%52W
Market Cap$8.51M
P/E—
PEG Ratio—
Div yield—
Beta0.42
BMRA Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-21.81%
Price vs S&P 500 (4W)-27.52%
VGM Score55.07
BMRA Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q1 2023 | — | -$0.96 | — |
BMRA Analyst Recommendations
Apr 2022
May 2022
Jun 2022
Jul 2022
4.29
4.29
4.29
4.29
Industry Peers — In Vitro Diagnostics(18)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|---|---|---|
BMRABIOMERICA INC | B | D | B | 1.9x | -16.2% | 8.1% | — | $1.85 |
| IDXXIdexx Laboratories Inc | D | B | B | 9.7x | 12.8% | 62.5% | 14.3% | $560.36 |
| LNTHLantheus Holdings, Inc | C | B | B | 4.2x | 2.4% | 61.0% | 40.7% | $99.70 |
| NEOGNeogen Corp | C | C | A | 2.9x | -0.3% | 47.4% | — | $11.81 |
| CLDXCelldex Therapeutics, Inc | F | F | C | 13683.0x | -97.3% | 17.6% | — | $27.53 |
| NTLAIntellia Therapeutics, Inc | D | D | C | 26.9x | 12.6% | — | — | $11.42 |
| QDELQuidelOrtho Corporation Common Stock | C | C | C | 0.3x | -2.5% | 44.6% | — | $12.91 |
| ACHVAchieve Life Sciences, Inc. | F | F | B | 36.8x | -89.3% | — | — | $6.38 |
| MYGNMyriad Genetics Inc | C | C | D | 0.5x | -3.2% | 68.8% | — | $3.98 |
| TKNOAlpha Teknova, Inc. Common Stock | D | C | B | 8.7x | 12.3% | 34.6% | — | $7.08 |
| NNNNAnbio Biotechnology Class A Ordinary Shares | F | C | F | 34.0x | -5.7% | 89.0% | — | $3.13 |
About BIOMERICA INC
Biomerica develops and markets medical diagnostic products for early detection and monitoring of chronic diseases, with a focus on gastrointestinal conditions, food intolerances, and diabetes. The company generates the majority of its revenue from Asia while maintaining a global presence across Europe, North America, the Middle East, and South America.